Impact of delay in the diagnosis on the severity of celiac disease
- PMID: 37963456
- DOI: 10.1111/jgh.16385
Impact of delay in the diagnosis on the severity of celiac disease
Abstract
Background and aim: Celiac disease (CeD) has now become a global disease with a worldwide prevalence of 0.67%. Despite being a common disease, CeD is often not diagnosed and there is a significant delay in its diagnosis. We reviewed the impact of the delay in the diagnosis on the severity of manifestations of CeD.
Methods: We reviewed clinical records of 726 consecutive patients with CeD from the Celiac Clinic database and the National Celiac Disease Consortium database. We extracted specific data including the demographics, symptoms at presentation, time of onset of symptoms, time to diagnosis from the onset of the symptoms, and relevant clinical data including fold-rise in anti-tissue transglutaminase antibody (IgA anti-tTG Ab) and severity of villous and crypt abnormalities as assessed using modified Marsh classification.
Results: The median duration between the onset of symptoms and the diagnosis of CeD was 27 months (interquartile range 12-60 months). A longer delay in the diagnosis of CeD from the onset of symptoms was associated with lower height for age, lower hemoglobin, higher fold rise in IgA Anti tTG titers, and higher severity of villous and crypt abnormalities. About 18% of patients presented with predominantly non-gastrointestinal complaints and had a longer delay in the diagnosis of CeD.
Conclusions: There is a significant delay in the diagnosis of CeD since the onset of its symptoms. The severity of celiac disease increases with increasing delay in its diagnosis. There is a need to keep a low threshold for the diagnosis of CeD in appropriate clinical settings.
Keywords: anemia; height; hemoglobin; serology; short stature; villous atrophy.
© 2023 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.J Clin Gastroenterol. 2015 Mar;49(3):212-7. doi: 10.1097/MCG.0000000000000105. J Clin Gastroenterol. 2015. PMID: 24583754
-
Validation of no-biopsy pathway for the diagnosis of celiac disease in Asian adults: a multicenter retrospective study.J Gastroenterol Hepatol. 2024 Mar;39(3):489-495. doi: 10.1111/jgh.16436. Epub 2023 Dec 14. J Gastroenterol Hepatol. 2024. PMID: 38095156
-
Prevalence of Celiac Disease in Patients with Nutritional Anemia in Western Part of India.J Assoc Physicians India. 2024 Nov;72(11):21-24. doi: 10.59556/japi.72.0744. J Assoc Physicians India. 2024. PMID: 39563112
-
Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.Gastroenterology. 2017 Sep;153(3):689-701.e1. doi: 10.1053/j.gastro.2017.05.015. Epub 2017 May 22. Gastroenterology. 2017. PMID: 28545781 Free PMC article. Review.
-
Celiac Disease in Children: A 2023 Update.Indian J Pediatr. 2024 May;91(5):481-489. doi: 10.1007/s12098-023-04659-w. Epub 2023 Jun 8. Indian J Pediatr. 2024. PMID: 37289309 Review.
Cited by
-
Proteomic analysis of plasma and duodenal tissue in celiac disease patients reveals potential noninvasive diagnostic biomarkers.Sci Rep. 2024 Dec 2;14(1):29872. doi: 10.1038/s41598-024-80391-5. Sci Rep. 2024. PMID: 39622892 Free PMC article.
-
Intestinal celiac disease - related autoantibodies.Front Immunol. 2025 Jun 6;16:1567416. doi: 10.3389/fimmu.2025.1567416. eCollection 2025. Front Immunol. 2025. PMID: 40547012 Free PMC article. Review.
-
Factors influencing diagnostic delays in celiac disease.World J Gastroenterol. 2025 Aug 14;31(30):109585. doi: 10.3748/wjg.v31.i30.109585. World J Gastroenterol. 2025. PMID: 40904886 Free PMC article.
-
Insights into coeliac disease diagnosis: a 2021-2023 overview of diagnostic approach and delays in children in Slovenia.Wien Med Wochenschr. 2024 Sep;174(11-12):257-261. doi: 10.1007/s10354-024-01045-9. Epub 2024 Jun 5. Wien Med Wochenschr. 2024. PMID: 38836948 Free PMC article.
-
Nationwide survey of coeliac disease serology testing in the UK.BMJ Open Gastroenterol. 2025 Aug 5;12(1):e001900. doi: 10.1136/bmjgast-2025-001900. BMJ Open Gastroenterol. 2025. PMID: 40764046 Free PMC article.
References
-
- Leonard MM, Sapone A, Catassi C, Fasano A. Celiac disease and nonceliac gluten sensitivity: a review. JAMA 2017; 318: 647-656.
-
- Makharia GK, Singh P, Catassi C et al. The global burden of coeliac disease: opportunities and challenges. Nat Rev Gastroenterol Hepatol 2022; 19: 313-327.
-
- Caio G, Volta U, Sapone A et al. Celiac disease: a comprehensive current review. BMC Med 2019; 17: 142.
-
- Green PHR, Stavropoulos SN, Panagi SG et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001; 96: 126-131.
-
- Cranney A, Zarkadas M, Graham ID et al. The Canadian celiac health survey. Dig Dis Sci 2007; 52: 1087-1095.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous